Global Nattokinase Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Nattokinase market size was valued at USD 34 million in 2022 and is forecast to a readjusted size of USD 57 million by 2029 with a CAGR of 7.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of Nattokinase include Japan Bio Science Laboratory, Daiwa Pharmaceutical, Contek Life Science, etc. The top three players hold a share over 62%.
Asia-Pacific is the largest market, has a share about 61%, followed by North America, and Europe, with share 19% and 11%, separately.
In terms of product type, 10001-20000 Fu/g is the largest segment, occupied for a share of 57%.
Nattokinase can be mainly used in Dietary Supplement, Dietary Supplement has a share about 88%.
A traditional Japanese food “Natto” is a food made from soybeans fermented by Bacillus natto, and has been eaten since about 1,200 years ago. Enzymes that Bacillus natto produce by fermentation include protease and Dr. Oshima at Hokkaido Imperial University reported its purification and characteristics. Since then, it was investigated as a serine protease, and, in 1980s, the enzyme that degrades fibrin proteins (a cause of thrombi) was named as “Nattokinase”. Nattokinase is found in the sticky part of Natto.
Functions of Nattokinase include directly degrading a fibrin (the main component of thrombi), activating pro-urokinase (precursor for urokinase that is an thrombolytic enzyme in the body) and increasing the amount of tissue plasminogen activator (t-PA) that produces a thrombolytic enzyme, plasmin. In addition, recent research has revealed that Nattokinase has a function of degrading plasminogen activator inhibitor, PAI-1 and reducing the euglobulin lysis time, and therefore, it has a function of improving the thrombolytic activity. Furthermore, the reduction of blood pressure has also been confirmed.
This report is a detailed and comprehensive analysis for global Nattokinase market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nattokinase market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Nattokinase market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Nattokinase market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Nattokinase market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nattokinase
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nattokinase market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Japan Bio Science Laboratory, Daiwa Pharmaceutical, Contek Life Science, Sungen Bioscience and Eiffel Biotech and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Nattokinase market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0-10000 Fu/g
10001-20000 Fu/g
Above 20001 Fu/g
Market segment by Application
Dietary Supplement
Others
Major players covered
Japan Bio Science Laboratory
Daiwa Pharmaceutical
Contek Life Science
Sungen Bioscience
Eiffel Biotech
Vedan Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nattokinase product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nattokinase, with price, sales, revenue and global market share of Nattokinase from 2018 to 2023.
Chapter 3, the Nattokinase competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nattokinase breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nattokinase market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nattokinase.
Chapter 14 and 15, to describe Nattokinase sales channel, distributors, customers, research findings and conclusion.